CD4-induced epitopes in the HIV envelope glycoprotein, gp120

Anthony L DeVico1

  • 1Division of Basic and Vaccine Research, Institute of Human Virology, University of Maryland Biotechnology Institute, Baltimore, MD 21201, USA. devico@umbi.umd.edu

Current HIV Research
|November 30, 2007
PubMed
Summary

Conserved CD4-induced epitopes on the HIV gp120 protein are key targets for developing vaccines and therapies against diverse HIV strains. Understanding their accessibility, antigenicity, and immunogenicity is crucial for advancing HIV treatment strategies.